201 related articles for article (PubMed ID: 29615666)
1. Insensitivity to atorvastatin is associated with increased accumulation of intracellular lipid droplets and fatty acid metabolism in breast cancer cells.
Lettiero B; Inasu M; Kimbung S; Borgquist S
Sci Rep; 2018 Apr; 8(1):5462. PubMed ID: 29615666
[TBL] [Abstract][Full Text] [Related]
2. High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer.
Kimbung S; Lettiero B; Feldt M; Bosch A; Borgquist S
Oncotarget; 2016 Sep; 7(37):59640-59651. PubMed ID: 27458152
[TBL] [Abstract][Full Text] [Related]
3. The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells.
Gbelcová H; Svéda M; Laubertová L; Varga I; Vítek L; Kolář M; Strnad H; Zelenka J; Böhmer D; Ruml T
Lipids Health Dis; 2013 Aug; 12():126. PubMed ID: 23961716
[TBL] [Abstract][Full Text] [Related]
4. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells.
Göbel A; Breining D; Rauner M; Hofbauer LC; Rachner TD
Cell Death Dis; 2019 Jan; 10(2):91. PubMed ID: 30692522
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase degrader, SR-12813, counteracts statin-induced upregulation of HMG-CoA reductase and augments the anticancer effect of atorvastatin.
Zhou Y; Tashiro J; Kamatani S; Irie N; Suzuki A; Ishikawa T; Warita K; Oltvai ZN; Warita T
Biochem Biophys Res Commun; 2023 Oct; 677():13-19. PubMed ID: 37541087
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl-CoA desaturase 1 deficiency exacerbates palmitate-induced lipotoxicity by the formation of small lipid droplets in pancreatic β-cells.
Janikiewicz J; Dobosz AM; Majzner K; Bernas T; Dobrzyn A
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166711. PubMed ID: 37054998
[TBL] [Abstract][Full Text] [Related]
7. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
[TBL] [Abstract][Full Text] [Related]
8. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S
Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2-mediated arachidonic acid metabolism under high fatty acid conditions.
Zhao Z; Liu X; Xiang Y; Hou Z; He K; Zhong G; Hu J; Cai D; Liu Y; Ren J; Gong J; Zhao L
Cancer Sci; 2024 Feb; 115(2):477-489. PubMed ID: 38081591
[TBL] [Abstract][Full Text] [Related]
10. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells.
Cerda A; Bortolin RH; Manriquez V; Salazar L; Zambrano T; Fajardo CM; Hirata MH; Hirata RDC
Pharmacol Rep; 2021 Jun; 73(3):868-880. PubMed ID: 33721286
[TBL] [Abstract][Full Text] [Related]
11. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin preferentially inhibits the growth of high ZEB-expressing canine cancer cells.
Ishikawa T; Osaki T; Sugiura A; Tashiro J; Warita T; Hosaka YZ; Warita K
Vet Comp Oncol; 2022 Mar; 20(1):313-323. PubMed ID: 34657361
[TBL] [Abstract][Full Text] [Related]
13. Ethanol extracts of chickpeas alter the total lipid content and expression levels of genes related to fatty acid metabolism in mouse 3T3-L1 adipocytes.
Shinohara S; Gu Y; Yang Y; Furuta Y; Tanaka M; Yue X; Wang W; Kitano M; Kimura H
Int J Mol Med; 2016 Aug; 38(2):574-84. PubMed ID: 27353085
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin decreases stearoyl-CoA desaturase gene expression in THP-1 macrophages incubated with oxidized LDL.
Martín-Fuentes P; García-Otín AL; Calvo L; Gómez-Coronado D; Civeira F; Cenarro A
Lipids; 2009 Feb; 44(2):115-23. PubMed ID: 18982375
[TBL] [Abstract][Full Text] [Related]
15. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
16. CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin.
Tashiro J; Sugiura A; Warita T; Irie N; Dwi Cahyadi D; Ishikawa T; Warita K
J Pharmacol Sci; 2023 Nov; 153(3):104-112. PubMed ID: 37770151
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells.
Hu MB; Zhang JW; Gao JB; Qi YW; Gao Y; Xu L; Ma Y; Wei ZZ
Ultrastruct Pathol; 2018; 42(5):409-415. PubMed ID: 30300062
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern.
Eliasson P; Svensson RB; Giannopoulos A; Eismark C; Kjær M; Schjerling P; Heinemeier KM
PLoS One; 2017; 12(3):e0172797. PubMed ID: 28264197
[TBL] [Abstract][Full Text] [Related]
19. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
[TBL] [Abstract][Full Text] [Related]
20. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
Conde K; Pineda G; Newton RS; Fernandez ML
Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
